Description: Informative discussion about pricing techniques, including: [1] uses of return on investment [ROI], GAAP return on equity [ROE], and universal life [UL] and other profit measures, [2] scenario testing, [3] expenses, [4] target surplus, and [5] federal-income-tax considerations. From the 1988 Record of Society of Actuaries, Vol. 14, No. 2.

Description: This reinsurance refresh session will review different types of reinsurance, main reinsurance regulations and resources, key reinsurance treaty provisions, as well as recent developments in reinsurance. We will also introduce LEARN, an education initiative sponsored by the SOA Reinsurance Section to help improve communication with regulators.

Description: Different mortality projection methodologies are utilized by actuaries across applications and practice areas. As a result, the SOA’s Longevity Advisory Group (“Advisory Group”) developed a single framework to serve as a consistent base for practitioners in projecting mortality improvement. The Mortality Improvement Model, MIM-2021, Tools and User Guides, compose the consistent approach

Description: 1993 SOA Spring Meeting, Boston. The panel discussed developments in products that involve multiple lives. Topics included: 1. Last to die products. 2. First to die products. 3. Variable products. 4. Reinsurance. 5. Market trends.

Description: In session 75 PD of the New York Annual Meeting panelists explore practical considerations of maintaining compliance with federal income tax definition of life insurance rules. From the Record of the Society of Actuaries, Vol. 24, No. 3.

Description: From a session at a meeting of the Society of Actuaries held in San Diego, CA, June 22-23, 2000 Topics covered in this session included: 1. Which customer segments may or may not be Internet-literate and how they can be identified, 2. How to determine the needs of identified customer segments and which of these needs can be served through the Internet, 3. Product consideration given Internet distribution, including design, agent involvement, and regulatory/compliance considerations.